Skip to content

Study · Not a test of the peptide alone · 2008

3 results

Effect of tetrapeptides Lys-Glu-Asp-Gly and Ala-Glu-Asp-Gly on the structure and function of the thyroid gland in neonatally hypophysectomized chickens.

Kuznik BI, Pateyuk AV, Rusaeva NS

Bulletin of experimental biology and medicine1 Jan 2008Cited by 1 (Europe PMC)

PMID19024016 (opens in a new tab)DOI10.1007/s10517-008-0033-6 (opens in a new tab)PepBankPUB-19024016
Publisher pagePubMedAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone3

In this study, Epitalon was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Epitalon.

  1. 01AnimalNot a test of Epitalon aloneAnimal study (in vivo)Efficacy outcome

    In hypophysectomized chickens, administration of the two tetrapeptides, including Ala-Glu-Asp-Gly, for 40 days was followed by higher concentrations of thyrotropic hormone.

    In plain wordsIn chickens without a pituitary gland, the peptides were followed by higher levels of thyroid-stimulating hormone after 40 days.

    Peptide
    Epitalon
    Outcome
    IncreaseThyrotropic hormone concentration
    Study

    chickenn: not reported in source

    Neonatally hypophysectomized chickens
    Outcome group
    Thyroid function · Endocrine and hormones

    Source sentences

    Summary
    Administration of these tetrapeptides to hypophysectomized chickens for 40 days was followed by an increase in the concentrations of thyrotropic hormone and thyroid hormones and recovery of thyroid gland structure.

    In this study, Epitalon was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Epitalon.

  2. 02AnimalNot a test of Epitalon aloneAnimal study (in vivo)Efficacy outcome

    In hypophysectomized chickens, administration of the two tetrapeptides, including Ala-Glu-Asp-Gly, for 40 days was followed by higher concentrations of thyroid hormones.

    In plain wordsIn chickens without a pituitary gland, the peptides were followed by higher thyroid hormone levels after 40 days.

    Peptide
    Epitalon
    Outcome
    IncreaseThyroid hormone concentrations
    Study

    chickenn: not reported in source

    Neonatally hypophysectomized chickens
    Outcome group
    Thyroid function · Endocrine and hormones

    Source sentences

    Summary
    Administration of these tetrapeptides to hypophysectomized chickens for 40 days was followed by an increase in the concentrations of thyrotropic hormone and thyroid hormones and recovery of thyroid gland structure.

    In this study, Epitalon was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Epitalon.

  3. 03AnimalNot a test of Epitalon aloneAnimal study (in vivo)Efficacy outcome

    In hypophysectomized chickens, administration of the two tetrapeptides, including Ala-Glu-Asp-Gly, for 40 days was followed by recovery of thyroid gland structure.

    In plain wordsIn chickens without a pituitary gland, the peptides were followed by recovery of thyroid gland structure after 40 days.

    Peptide
    Epitalon
    Outcome
    Not applicableThyroid gland structure
    Study

    chickenn: not reported in source

    Neonatally hypophysectomized chickens
    Outcome group
    Thyroid function · Endocrine and hormones

    Source sentences

    Summary
    Administration of these tetrapeptides to hypophysectomized chickens for 40 days was followed by an increase in the concentrations of thyrotropic hormone and thyroid hormones and recovery of thyroid gland structure.

    In this study, Epitalon was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Epitalon.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    9 Oct 2026, 18:17 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:47 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.